Evaluating [18F]-AlF-FAPI-74 PET/CT for diagnosis of the unfavourable CMS4 colorectal cancer subtype (FoCus study): protocol for a prospective, observational, proof-of-concept clinical study
Abstract Introduction Consensus molecular subtype 4 (CMS4) colorectal cancer (CRC) is characterised by stromal activation, therapy resistance and poor prognosis. Current CMS4 assessment relies on tissue sampling, which is limited by sampling bias due to inter-lesion and intra-lesion heterogeneity. Fibroblast activation...